Intramural Hematoma clinical trials at University of California Health
2 research studies open to eligible people
Endovascular Repair Of Ascending Aortic Pathologies
open to eligible people ages 18 years and up
The purpose of this study is to investigate the outcome of patients with pathologies of the ascending thoracic aorta (diseases in the great blood vessel or artery that leads away from the heart) including type A aortic dissection, retrograde type A…
at UCLA
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
open to eligible people ages 18 years and up
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously…
at UCSD
Our lead scientists for Intramural Hematoma research studies include Rodney A White, M.D. Eugene Golts, M.D. John Lane, M.D..
Last updated: